Clinical Trials on CD30 Positive Transformed Mycosis Fungoides

Total 3394 results

Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infections

China
Sheba Medical Center
The Israel Science Foundation

Recruiting

Mother to Newborn Transmission of Staphylococcus Aureus and Dynamics of S.Aureus Carriage During the First Years Life

Staphylococcus Aureus

Israel
University of Calgary
Canadian Institutes of Health Research (CIHR); Alberta Health services

Completed

C Difficile Near-patient Diagnostics

Clostridium Difficile

Canada
Pfizer

Terminated

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Pneumococcal Infections

United States
Pfizer

Completed

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

Pneumococcal Infections

United States, Australia, Canada, Chile, New Zealand, Poland, Russian Federation
Centre Hospitalier Universitaire de Saint Etienne
Sanofi Pasteur, a Sanofi Company

Completed

Ex Vivo Evaluation of Immunity Activation Face to S. Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients (ANTISTAPH)

Staphylococcus Aureus

France
Pfizer

Completed

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

Pneumococcal Infections

United States
Rothman Institute Orthopaedics

Unknown

Probiotics Pilot Project

Staphylococcus Aureus

United States
Pfizer

Completed

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Pneumococcal Infections

Japan
Telethon Kids Institute
Papua New Guinea Institute of Medical Research

Completed

PCV13 in Non-pregnant Papua New Guinean Women

Pneumococcal Infections

Papua New Guinea
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)

Pneumococcal Infections

United States, Canada, Denmark, Finland, Israel, Spain
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)

Pneumococcal Infections
Mayo Clinic

Completed

Fresh Versus Frozen Stool for Fecal Transplant in Children

Clostridium Difficile

United States
GlaxoSmithKline

Completed

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

Infections, Streptococcal

Poland, Philippines
Pfizer

Completed

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Clostridium Difficile

United States, Canada
GlaxoSmithKline

Completed

Booster and Catch-up Vaccination With Vaccine GSK1024850A

Infections, Streptococcal

India
National Institute of Allergy and Infectious Diseases...

Completed

Network on Antimicrobial Resistance in Staphylococcus Aureus

Staphylococcus Aureus

United States
Sinovac Biotech Co., Ltd

Completed

Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly

Pneumococcal Infections

China
Jared Brooks
Northwestern Medicine

Completed

Chlorhexidine Bathing Effect on Clostridium Difficile Rates

Clostridium Difficile

United States
Destiny Pharma Plc

Completed

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Staphylococcal Infection

United Kingdom
SK Chemicals Co., Ltd.

Completed

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

Pneumococcal Infections
University of Wisconsin, Madison
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Probiotics for Clostridium Difficile Infection in Older Adults (PICO)

Clostridium Difficile

United States
Colleen Kelly

Unknown

Fecal Transplant for Relapsing C. Difficile Infection

Clostridium Difficile

United States
Daniel Freedberg

Completed

Effects of Gastric Acid on Colonic Microbiome

Clostridium Difficile

United States
Astellas Pharma Europe B.V.

Terminated

To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis (DAISY)

Clostridium Difficile

France, Germany, Netherlands, Spain
Virginia Commonwealth University
Cubist Pharmaceuticals LLC; University HealthSystem Consortium

Completed

Antimicrobial Drug Use and Resistant Staphylococcus Aureus

Staphylococcus Aureus

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children

Pneumococcal Infections

Poland
University of Helsinki
Soft Protector; The Finnish Funding Agency for Technology and Innovation (TEKES)

Completed

Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation

Clostridium Difficile
Lymphoma Study Association

Terminated

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

CD20-Positive Large B-Cell Lymphoma

France
Cumberland Pharmaceuticals

Completed

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) (FAST2)

Infections, Gram-positive Bacterial

United States
Aarhus University Hospital
Linkoeping University; University of Gondar

Not yet recruiting

Increased Tuberculosis Case Detection - a Cluster-randomized Trial Combining Available Resources and Novel Strategies for High Endemic Areas (DiOpTB)

Tuberculosis
Freundeskreis Für Internationale Tuberkulosehilfe...

Not yet recruiting

Evaluation of CAD-based Triage for CXR Interpretation During TB Screening

Tuberculosis

Vietnam
GlaxoSmithKline

Recruiting

A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

Tuberculosis

Spain
Liverpool School of Tropical Medicine
Fred Hutchinson Cancer Center; University of Oxford; University of Liverpool; Malawi-Liverpool-Wellcome... and other collaborators

Not yet recruiting

A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi (MLWBCGCHIM)

Tuberculosis

Malawi
Sohag University

Recruiting

Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate

Tuberculosis

Egypt
Centre Hospitalier Universitaire, Amiens

Recruiting

Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis (ISOBK)

Tuberculosis

France
University of California, San Francisco
Johns Hopkins University; University of California, Irvine; University Hospital... and other collaborators

Recruiting

Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT)

Tuberculosis

Zambia, Philippines, Nigeria
Bill & Melinda Gates Medical Research Institute
Merck Sharp & Dohme LLC

Recruiting

Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults

Tuberculosis

United States
Assiut University

Not yet recruiting

KAP Regarding Tuberculosis Among Physicians in Assiut City

Tuberculosis
Klaus Reither
Radboud University Medical Center; Charite University, Berlin, Germany; Institute... and other collaborators

Recruiting

Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa

Tuberculosis

Lesotho, South Africa
St George's, University of London
University of Nottingham; Medical Research Council; Public Health England

Recruiting

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease (iGBS3)

Streptococcus Agalactiae Infection

United Kingdom
Beijing Chest Hospital

Recruiting

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Tuberculosis

China
Bharat Biotech International Limited

Active, not recruiting

Tuberculosis Vaccine in Healthy Indian Adults (BBV169/2023)

Tuberculosis

India
Institut National de la Santé Et de la Recherche...
UNITAID

Completed

Evaluation of Four Stool Processing Methods Combined With Xpert MTB/RIF Ultra for Diagnosis of Intrathoracic Paediatric TB (TB-Speed - Stool Processing)

Tuberculosis

Zambia, Uganda
University of Virginia
University of Florida; Rutgers, The State University of New Jersey

Completed

Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults (PEE-TB)

Tuberculosis

United States
Emergent BioSolutions
Department of Health and Human Services

Completed

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Anthrax

United States
Emergent BioSolutions
National Institutes of Health (NIH)

Completed

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

Anthrax

United States
Fred Hutchinson Cancer Center
Merck Sharp & Dohme LLC

Completed

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Tuberculosis

United States

3

Subscribe